Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.73 → 3.71 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CCNE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Dividend per share maintained at $0.19 per quarter | The company maintains its dividend at $0.19 per share. | Intact | dividend per share falls below $0.19 in any quarter | Dividend per share: $0.19 per share FY2026-Q3; GAAP. Published target: >= $0.19 per share quarterly dividend. Target period is not explicitly aligned with this observation. Nov 4, 20260.19 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking business with a growth-and-execution thesis, rather than a turnaround story. The long-term thesis is intact, but confidence has eased from high to medium, and management execution remains uneven.
The valuation evidence tags CCNE as stretched, while also indicating it is cheap versus peers. The expectations gap is small, and the evidence rates fragility as low, so the setup does not show a broad stack of valuation and execution concerns.
Near term, recent financial performance is strong, with earnings beats in July and October and third-quarter organic loan growth. Cost discipline remains mixed: PPNR edged lower from the prior quarter, partly due to higher noninterest expense, while the branch-footprint work showed only a modest reduction in deposits designated for sale.
The multi-year view depends on continued lending and treasury relationship growth, alongside better evidence of overhead discipline and progress in optimizing the footprint. Near term, a guidance cut or rate cuts from the current 3.88% would be risks; continued strong earnings and guidance from financial-sector bellwethers would support sector momentum.
For the next one to three years, the thesis rests on strong recent performance continuing while mixed execution improves; the valuation is tagged as stretched despite being cheap versus peers. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| CNB Financial keeps growing net income, which rose to $27 million in 2026-Q1. |
| Improving |
| net income falls below $27 million in 2026-Q1 |
Net income: $28.061M FY2026-Q3; GAAP. Published target: >= $27 million net income. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 4, 202628,061,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Repurchase up to 500,000 shares under 2026 buyback program | It also started a share buyback program for up to 500,000 shares. | Intact | Buyback program not implemented or canceled in 2026 | Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.84 → $3.71 · observed estimates
$0.32B → $0.37B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.84 | $321,433,330 | 4 / 3 |
| 2026-07-25 | $3.80 | $338,300,000 | 4 / 3 |
| 2026-07-26 | $3.80 | $338,300,000 | 4 / 3 |
| 2026-07-27 | $3.80 | $334,075,000 | 4 / 4 |
| 2026-07-28 | $3.80 | $334,075,000 | 4 / 4 |
| 2026-07-29 | $3.80 | $334,150,000 | 4 / 4 |
| 2026-07-30 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-07-31 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-01 | $3.80 | $334,150,000 | 4 / 4 |
| 2026-08-02 | $3.80 | $334,150,000 | 4 / 4 |
| 2026-08-03 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-04 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-05 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-06 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-07 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-08 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-09 | $3.73 | $332,625,000 | 4 / 4 |
| 2026-08-10 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-11 | $3.73 | $332,625,000 | 4 / 4 |
| 2026-08-12 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-13 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-14 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-15 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-16 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-17 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-18 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-19 | $3.80 | $371,966,667 | 3 / 4 |
| 2026-08-20 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-21 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-22 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-23 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-24 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-25 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-26 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-27 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-28 | $3.73 | $368,700,000 | 3 / 4 |
| 2026-08-29 | $3.72 | $368,275,000 | 4 / 5 |
| 2026-08-30 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-08-31 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-01 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-02 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-03 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-04 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-05 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-06 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-07 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-08 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-09 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-10 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-11 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-12 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-13 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-14 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-15 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-16 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-17 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-18 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-19 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-20 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-21 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-22 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-23 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-24 | $3.72 | $368,275,000 | 4 / 3 |
| 2026-09-25 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-09-26 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-09-27 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-09-28 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-09-29 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-09-30 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-10-01 | $3.73 | $368,320,000 | 5 / 4 |
| 2026-10-02 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-03 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-04 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-05 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-06 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-07 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-08 | $3.73 | $368,580,000 | 5 / 4 |
| 2026-10-09 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-10 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-11 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-12 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-13 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-14 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-15 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-16 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-17 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-18 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-19 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-20 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-21 | $3.74 | $368,580,000 | 5 / 4 |
| 2026-10-22 | $3.74 | $368,220,000 | 5 / 4 |
| 2026-10-23 | $3.73 | $367,485,460 | 5 / 4 |
| 2026-10-24 | $3.73 | $367,485,460 | 5 / 4 |
| 2026-10-25 | $3.73 | $367,485,460 | 5 / 4 |
| 2026-10-26 | $3.73 | $367,485,460 | 5 / 4 |
| 2026-10-27 | $3.73 | $367,485,460 | 5 / 4 |
| 2026-10-28 | $3.72 | $367,605,460 | 5 / 4 |
| 2026-10-29 | $3.72 | $367,605,460 | 5 / 4 |
| 2026-10-30 | $3.72 | $367,605,460 | 5 / 4 |
| 2026-10-31 | $3.73 | $367,505,460 | 5 / 4 |
| 2026-11-01 | $3.73 | $367,505,460 | 5 / 4 |
| 2026-11-02 | $3.73 | $367,505,460 | 5 / 4 |
| 2026-11-03 | $3.73 | $367,505,460 | 5 / 4 |
| 2026-11-04 | $3.71 | $366,585,460 | 5 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.